0001179110-16-033197.txt : 20161219
0001179110-16-033197.hdr.sgml : 20161219
20161219163445
ACCESSION NUMBER: 0001179110-16-033197
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161215
FILED AS OF DATE: 20161219
DATE AS OF CHANGE: 20161219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Onconova Therapeutics, Inc.
CENTRAL INDEX KEY: 0001130598
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
BUSINESS PHONE: 267-759-3681
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS, INC.
DATE OF NAME CHANGE: 20090526
FORMER COMPANY:
FORMER CONFORMED NAME: ONCONOVA THERAPEUTICS INC
DATE OF NAME CHANGE: 20001226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kumar Ramesh
CENTRAL INDEX KEY: 0001580074
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36020
FILM NUMBER: 162059331
MAIL ADDRESS:
STREET 1: 375 PHEASANT RUN
CITY: NEWTOWN
STATE: PA
ZIP: 18940
4
1
edgar.xml
FORM 4 -
X0306
4
2016-12-15
0
0001130598
Onconova Therapeutics, Inc.
ONTX
0001580074
Kumar Ramesh
C/O ONCONOVA THERAPEUTICS, INC.
375 PHEASANT RUN
NEWTOWN
PA
18940
1
1
0
0
President and CEO
Stock Option (right to purchase)
2.65
2016-12-15
4
A
0
12673
0
A
2026-12-15
Common Stock
12673
12673
D
These options vest over three years in 36 equal monthly installments.
/s/ Mark Guerin as attorney-in-fact
2016-12-19